Paxlovid’s Double-Edged Sword: Treating COVID-19 and the Risk of Viral Load Rebound
The conversation of VLR has sparked a discussion as to whether or not other COVID-19 treatment agents are associated with a surge in symptoms and if so, how those agents compare with the rebound effect of nirmatrelvir/ritonavir.